MARIFI CALAMLAM: Open Payments
NPI 1710211230 · ABILENE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$749 in 29 payments from 6 companies in 2025. Trend: 2023 $905 · 2024 $562 · 2025 $749
Food & beverage: $749
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $224 |
| Abbott Laboratories | 12 | $174 |
| Novo Nordisk Inc | 10 | $140 |
| GlaxoSmithKline, LLC. | 2 | $136 |
| Inspire Medical Systems, Inc. | 1 | $54 |
| PFIZER INC. | 1 | $22 |
Products named: AIRSUPRA, Ozempic, AREXVY, ESPRIT, ULTREON, BREZTRI, INSPIRE, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
